SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-204153
Filing Date
2020-07-30
Accepted
2020-07-30 18:43:08
Documents
87
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d939099d10q.htm   iXBRL 10-Q 1648197
2 EX-31.1 d939099dex311.htm EX-31.1 10782
3 EX-31.2 d939099dex312.htm EX-31.2 10739
4 EX-32.1 d939099dex321.htm EX-32.1 7214
  Complete submission text file 0001193125-20-204153.txt   7964927

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rgen-20200630.xsd EX-101.SCH 51271
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgen-20200630_cal.xml EX-101.CAL 53491
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgen-20200630_def.xml EX-101.DEF 473883
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20200630_lab.xml EX-101.LAB 501404
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20200630_pre.xml EX-101.PRE 512757
10 EXTRACTED XBRL INSTANCE DOCUMENT d939099d10q_htm.xml XML 1316520
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-14656 | Film No.: 201061377
SIC: 2836 Biological Products, (No Diagnostic Substances)